Browsing: Weight Loss

Neurocrine Biosciences has initiated a Phase 1 clinical trial to test the safety and tolerability of NBIP-‘1968, a novel triple agonist drug targeting GLP-1, GIP, and glucagon receptors for obesity treatment. This investigational drug aims to address obesity by engaging three metabolic mechanisms to regulate appetite, energy balance, and glycemic control. The study will involve…

But as obesity rates continue to climb in the United States, doctors and scientists increasingly recognize that weight is influenced by more than calories consumed and calories burned. Genetics, hormones, medications, environmental exposures and other biological factors all can influence how the body gains, loses and maintains weight